Table 13.6g

Immunosuppression Use for Maintenance Between Discharge

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		47	51	48	27	33	29	40	35	31	31
Tx with Follow-up Immunosuppression Info		24	28	29	21	21	13	30	26	20	26
Corticosteroids	Any in Category	95.8%	96.4%	100.0%	95.2%	100.0%	92.3%	100.0%	100.0%	100.0%	100.0%
Corticosteroids	Steroids	95.8%	96.4%	100.0%	95.2%	100.0%	92.3%	100.0%	100.0%	100.0%	100.0%
Cyclosporine	Any in Category	62.5%	53.6%	58.6%	47.6%	52.4%	38.5%	36.7%	50.0%	15.0%	7.7%
	Sandimmmune	0.0%	0.0%	6.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Neoral	62.5%	53.6%	44.8%	42.9%	47.6%	23.1%	26.7%	30.8%	5.0%	3.8%
	Gengraf	0.0%	0.0%	6.9%	4.8%	4.8%	15.4%	10.0%	19.2%	10.0%	3.8%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Tacrolimus	Any in Category	37.5%	50.0%	58.6%	76.2%	66.7%	76.9%	73.3%	84.6%	90.0%	96.2%
Tacrolimus	Tacrolimus	37.5%	50.0%	58.6%	76.2%	66.7%	76.9%	73.3%	84.6%	90.0%	96.2%
Antimetabolites	Any in Category	95.8%	89.3%	93.1%	95.2%	95.2%	84.6%	90.0%	100.0%	100.0%	76.9%
	Mycophenolate Mofetil	54.2%	42.9%	48.3%	47.6%	38.1%	38.5%	43.3%	53.8%	60.0%	65.4%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	3.8%
	Azathioprine	41.7%	46.4%	44.8%	47.6%	57.1%	46.2%	46.7%	46.2%	40.0%	7.7%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	4.2%	3.6%	10.3%	0.0%	9.5%	0.0%	6.7%	7.7%	0.0%	3.8%
	Sirolimus	4.2%	3.6%	10.3%	0.0%	9.5%	0.0%	6.7%	7.7%	0.0%	3.8%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%